Saturday, August 12, 2017 8:23:23 AM
"We incurred net income of $755,667 and $352,361, respectively, for the three and six months ended June 30, 2017 as compared to a net loss of $613,210 and 1,282,760, respectively, for the three and six months ended June 30, 2016."
As noted previously, the figures that are being described as "net income of $755,667 and $352,361, respectively, for the three and six months ended June 30, 2017" are actually NET LOSSES. Simple math mistakes happen every day in accounting and in SEC filings. When mistakes like this one occur...representing MATERIAL Losses as Income, not only in the financial statements but the text, it's impossible to believe that management wasn't aware of them unless they certified them without reading them first.
BTW the above isn't the only mistake in the filing, but it's by far the most inexplicable.
This doesn't just warrant an amended filing, it cries out for an explanation. OTC company executives here and elsewhere are known for their failure to execute on the expectations they raise. This isn't that...it's worse. The stupidity of it is the only plausible argument against it being fraudulent.
But can it core A apple?
Yes Ralph, of course it can core A apple.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM